New registry to monitor Seladelpar's Real-World impact on PBC
Disease control
Not yet recruiting
This study will follow 100 adults with primary biliary cirrhosis (PBC) who are taking seladelpar as part of their routine care in Germany and Switzerland. Researchers want to see if the drug helps control the disease by improving liver test results after 48 weeks. This is an obse…
Sponsor: University of Leipzig • Aim: Disease control
Last updated May 14, 2026 12:03 UTC